We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Gab8.5
GABA Research
Mostly mechanism / observationalHigh safety
18 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most GABA studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality randomised trials published 2008–2026 with a typical study size of 88 participants.
Based on 18 studies · 9 RCTs · 1,130 total participants
Confidence
High
What the studies found
2helped· 16 more without graded effect data
By outcome
Anxiety & stressReduced acute anxiety and stress · 30-60 minutes
Mostly mechanism / observational8 studies
Sleep & insomniaMay reduce time to fall asleep · 30-60 minutes · GABAergic activity promotes deeper, more restorative sleep stages · 1-2 weeks · Inhibitory neurotransmitter support may improve sleep continuity · 1-2 weeks
Mostly mechanism / observational8 studies
Therapeutic & clinical
Mostly mechanism / observational5 studies
Safety profile
Mostly mechanism / observational4 studies
Depression & moodCalming effects support emotional regulation · 2-4 weeks
Mostly mechanism / observational3 studies
Neuroprotection & brain aging
Mostly mechanism / observational3 studies
Cognitive function
Too few graded studies2 studies
Heart & blood pressure
Too few graded studies2 studies
By the numbers
Pulled from 6 studies with measurable effects
Likely real effects
100%
across studies
People studied
1,130
typical study: 88 people
Strongest designs
9
0 pooled, 9 randomised
Showed benefit
100%
2/2 studies
How long studies ran
1–4 weeks
1
Populations Studied
Patients with insomnia1
Mild cognitive impairment and Alzheimer's disease patients1
Children and adolescents with ASD and/or ADHD1
Adults with moderate insomnia symptoms1
Active research area
14 studies in the last 5 years
200820172026
1Systematic ReviewCited 160×n=470 · medium study2020
Oral GABA supplementation showed benefits for stress reduction and sleep quality across reviewed clinical trials.
Hepsomali P et al. · Nutrients (2020)
GABA supplementation reduced subjective stress markers within 30-60 minutes
Sleep quality improvements observed at doses of 100-300mg
Mechanism of action likely involves gut-brain axis signaling rather than direct BBB crossing
2Herbal remedies effect on GABAergic system and sleepSystematic ReviewCited 66×2021
Currently available evidence suggests that herbal extracts may exert some of their hypnotic and anxiolytic activity through interacting with GABA receptors and modulating GABAergic signaling in the brain, but their mechanism of action in the treatment of insomnia is not completely understood.
Bruni O et al. · Nutrients (2021)
Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states.
GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines.
Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control.
3Cognitive function and gut microbiome compositionSystematic Review2025
This review describes the role of the gut microbiome and probiotics in AD.
Ajith TA et al. · Nutritional neuroscience (2025)
Compared to healthy controls, mild cognitive impairment and AD were associated with low levels of Firmicutes and Bifidobacterium and high levels of Proteobacteria and Bacteroidetes.
Lactobacillus and Bifidobacterium species were effective in improving cognitive function.
More longitudinal research is needed to investigate precision medicine in patients with dysbiosis in the preclinical stages of the disease.
A better understanding of GABA may introduce new windows for its application in developing functional foods.
Hou D et al. · Critical reviews in food science and nutrition (2024)
Herein, this review provides a comprehensive insight on the dietary sources, enrichment technologies, processing effects of GABA, and its applications in food industry.
Furthermore, the various health benefits of GABA-enriched foods, mainly including neuroprotection, anti-insomnia, anti-depression, anti-hypertensive, anti-diabetes, and anti-inflammatory are also summarized.
The main challenges for future research on GABA are related to exploring high GABA producing strains, enhancing the stability of GABA during storage, and developing emerging enrichment technologies without affecting food quality and other active ingredients.
Adds direct RCT evidence for GABA's effect on sleep onset and quality in clinically defined insomnia, strengthening the mechanistic case for supplementation.
Yamatsu A et al. · Nutrients (2024)
GABA supplementation significantly reduced sleep onset latency compared to placebo
Significant improvements in overall Pittsburgh Sleep Quality Index scores in the GABA group
Subjective sleep satisfaction was higher in the treatment arm with no adverse events
7Symptomatology of autism spectrum disorder and ADHDRCTCited 10×n=80 · small study2025
This rct examined the effects of GABA.
Rojo-Marticella M et al. · Research on child and adolescent psychopathology (2025)
Noticeable benefit
← WorseNo effectBetter →
Likely real
A better comfort score (quality of life) was shown in children with ASD (probiotic: p = 0.010, Cohen's d = 0.722; placebo: p = 0.099, Cohen's d = 0.456).
The probiotics used, may improve hyperactivity-impulsivity in children with ASD or/and ADHD and quality of life in children with ASD.
Further research is warranted to explore probiotics as an adjunctive therapeutic intervention for NDs.Trial registration: clinicaltrials.gov Identifier: NCT05167110.
GABA supplementation elicited noteworthy enhancements in heart rate variability, emotional response, depression mitigation, and sleep efficiency following a 90-day supplementation.
Guimarães AP et al. · Journal of dietary supplements (2024)
Moreover, an improved emotional response was observed, characterized by diminished negative affect.
GABA supplementation yielded ameliorations in depression scores as per the Depression, Anxiety, and Stress Scale (DASS-21).
Notably, an augmented HRV was noted, attributed to heightened parasympathetic autonomic nervous system predominance.
12Insomnia severity index scoresRCTn=139 · medium study2026
This rct examined the effects of GABA.
Grant AD et al. · Scientific reports (2026)
Huge benefit
← WorseNo effectBetter →
Likely real
Participants were screened for at least moderate symptoms of insomnia and blindly assigned to receive either a placebo capsule or 5 billion CFU of Lp815 per day. 139 Individuals (5 billion CFU Lp815 n = 70, placebo n = 69) were evaluated, aged 44 ± 13 years, 51.1% female and 55.4% Caucasian.
Participants who received 5 billion CFU Lp815 exhibited significantly lower insomnia severity index scores at 6 weeks compared to placebo (p < 0.05).
This result was clinically meaningful, with 77.3% of participants in the 5 billion CFU Lp815 cohort exhibiting improvement by 4 + points in their insomnia severity index at week 6, compared to 57.8% in the placebo group (p = 0.02).
By delineating this gut-mediated neuromodulatory network, our study provides a novel theoretical foundation for the use of TP as a dietary strategy to ameliorate sleep disorders.
Hu B et al. · The Journal of nutritional biochemistry (2026)
These structural changes are accompanied by functional benefits, including enhanced intestinal barrier integrity and attenuated systemic inflammation.
Furthermore, gut microbiota metabolize TP into bioactive small molecules that enter systemic circulation, cross the blood-brain barrier (BBB), and modulate central neurotransmitters, notably serotonin (5-HT) and γ-aminobutyric acid (GABA).
By delineating this gut-mediated neuromodulatory network, our study provides a novel theoretical foundation for the use of TP as a dietary strategy to ameliorate sleep disorders.
Zuo Y et al. · European journal of medicinal chemistry (2026)
Representative chemical scaffolds are discussed to illustrate structure-based optimization strategies and lead identification approaches informed by high-resolution structural data.
This review summarizes recent progress in GABAA receptor targeting ligands, with an emphasis on distinct allosteric binding sites, regulatory mechanisms, and subtype-dependent pharmacological profiles.
Collectively, these advances highlight how structure-resolved insights are reshaping GABAAR drug discovery and enabling the development of next-generation therapeutics with improved efficacy and reduced adverse effects.
This systematic-review examined the effects of GABA.
Crockett C et al. · Advances in therapy (2025)
With nearly 40% of women's lives spent post-menopause, combined with the extensive amount of time women sometimes spend in perimenopause (up to 12%), when mental health challenges are noted to be most acute, effective menopause management should be an urgent public health priority.
Going forward, it is reassuring that oral GABA therapy has been well-tolerated and devoid of serious adverse effects.
Mick GJ et al. · Frontiers in endocrinology (2024)
Glutamate constitutes 10% of the amino acids in dietary protein and is preeminently concentrated in human milk.
Three diabetes-related therapeutic actions are ascribed to GABA, namely, increasing pancreatic β-cell content, attenuating excess glucagon and tamping down T-cell immune destruction.
These salutary actions have been observed in numerous rodent diabetes models that usually employed high or near-continuous GABA doses.
The purpose of this review is to attract researchers from various fields to focus on GABA research, promote multidisciplinary communications and collaborations, break down disciplinary barriers, stimulate innovative research ideas and methods, and advance the development and application of GABA in medicine, agriculture, food and other fields.
Zhang Q et al. · PeerJ (2024)
In this review, we first make an overview of GABA, focusing on its synthesis, metabolism, GABA receptors and physiological functions.
Next, we describe the industrial production methods of GABA.
Finally, we discuss the development of ligands for the GABA receptor binding site, the prospects of GABA production and application, as well as its clinical trials in potential drugs or compounds targeting GABA for the treatment of epilepsy.